NDAORALLY DISINTEGRATINGTABLET
Approved
Dec 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
CITALOPRAM HYDROBROMIDE (citalopram hydrobromide) by Dr. Reddy's Laboratories is unclear, but is presumed to be related to potentiation of serotonergic activity in the central nervous system (cns) resulting from its inhibition of cns neuronal reuptake of serotonin (5-ht). Approved for hot flashes, breast cancer, psychosocial effects of cancer and its treatment. First approved in 2005.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI) approved for hot flashes, breast cancer, and psychosocial effects of cancer treatment. It works by inhibiting CNS neuronal reuptake of serotonin (5-HT), potentiating serotonergic activity in the brain. The drug is available as an orally disintegrating tablet, offering patient convenience in oncology and symptom management settings.
LOE Approaching
Product approaching loss of exclusivity signals need for cost-containment and brand lifecycle management expertise rather than growth-focused commercial expansion.
Mechanism of Action
unclear, but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Worked on CITALOPRAM HYDROBROMIDE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.